Background Medication adherence is an important issue, not just health-related, for patients with haemophilia. Poor medication adherence to long-term therapies limits the potential of effective treatments to improve patients’ health-related quality of life. Objective The aim of this study was to investigate the association of reported medication adherence and health-related quality of life in patients with haemophilia. Setting Data were collected from patients at University Hospital Centre Zagreb, Croatia and at University Medical Centre Ljubljana, Slovenia. Method Adult male patients with severe or moderate haemophilia receiving prophylactic treatment were eligible for the study. Main outcome measure Implementation phase of medication adherence was assessed with the self-reported VERITAS-Pro instrument and health-related quality of life with SF-36v2. Results A total of 82 participants were included in the study (median age was 44.50, range 18–73 years). The majority of our participants reported being adherent to medication (83%). Participants showed better health in the mental health domains and Mental Component Summary than in the physical health domains and Physical Component Summary. After controlling for demographic, socioeconomic and clinical predictors, better reported medication adherence explained an additional 4–6% of better health variance in Bodily Pain and Social Functioning domains and Mental Component Summary. Conclusion We found that reported medication adherence can contribute to better health-related quality of life in patients with haemophilia. Since life with a chronic condition is demanding, it is an important finding that medication adherence to replacement therapy can improve life conditions for patients with haemophilia.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
Srivastava A, Brewer AK, Mauser-Bunschoten EP, Key NS, Kitchen S, Llinas A, et al. Guidelines for the management of hemophilia. Haemophilia. 2013;19:e1–47.
Stonebraker JS, Bolton-Maggs PHB, Soucie JM, Walker I, Brooker M. A study of variations in the reported haemophilia A prevalence around the world. Haemophilia. 2010;16:20–32.
Stonebraker JS, Bolton-Maggs PHB, Michael Soucie J, Walker I, Brooker M. A study of variations in the reported haemophilia B prevalence around the world. Haemophilia. 2012;18:e91–4.
Orphanet. The portal for rare diseases and orphan drug. https://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=GB&Expert=448. Accessed 29 Mar 2021.
Atilla B, Güney-Deniz H. Musculoskeletal treatment in haemophilia. EFORT Open Rev. 2019;4:230–9.
Van Vulpen LFD, Holstein K, Martinoli C. Joint disease in haemophilia: pathophysiology, pain and imaging. Haemophilia. 2018;24:44–9.
O’Hara J, Walsh S, Camp C, Mazza G, Carroll L, Hoxer C, et al. The impact of severe haemophilia and the presence of target joints on health-related quality-of-life. Health Qual Life Outcomes. 2018;16:1–8.
Zupancic Salek S (eds) Smjernice za dijagnostiku i liječenje hemofilije Zagreb Fotosoft d.o.o 978-953-7064-21-1 (2013)
World Health Organization. Adherence to long-term therapies: Evidence for action. Sabate E, editor. Geneva: World Health Organization; 2003. ISBN: 92 4 154599 2
Jüngst C, Gräber S, Simons S. Medication adherence among patients with chronic diseases: a survey-based study in pharmacies. QJM. 2019;112:505–12.
Llewellyn CD, Miners AH, Lee CA, Harrington C, Weinman J. The illness perceptions and treatment beliefs of individuals with severe haemophilia and their role in adherence to home treatment. Psychol Health. 2003;18:185–200.
Torres-Ortuño A, Cuesta-Barriuso R, Nieto-Munuera J, Galindo-Piñana P, López-Pina JA. The behaviour and perception of illness: modulating variables of adherence in patients with haemophilia. Vox Sang. 2018;113:577–83.
Krishnan S, Vietri J, Furlan R, Duncan N. Adherence to prophylaxis is associated with better outcomes in moderate and severe haemophilia: results of a patient survey. Haemophilia. 2015;21:64–70.
Ho S, Gue D, McIntosh K, Bucevska M, Yang M, Jackson S. An objective method for assessing adherence to prophylaxis in adults with severe haemophilia. Haemophilia. 2014;20:39–43.
Tran DQ, Barry V, Antun A, Ribeiro M, Stein S, Kempton CL. Physician trust and depression influence adherence to factor replacement: a single-centre cross-sectional study. Haemophilia. 2017;23:98–104.
De Moerloose P, Urbancik W, Van Den Berg HM, Richards M. A survey of adherence to haemophilia therapy in six European countries: results and recommendations. Haemophilia. 2008;14:931–8.
Conn VS, Ruppar TM, Enriquez M, Cooper P. Medication adherence interventions that target subjects with adherence problems: systematic review and meta-analysis. Res Social Adm Pharm. 2016;12:218–46.
Limperg PF, Terwee CB, Young NL, Price VE, Gouw SC, Peters M, et al. Health-related quality of life questionnaires in individuals with haemophilia: a systematic review of their measurement properties. Haemophilia. 2017;23:497–510.
Varaklioti A, Kontodimopoulos N, Katsarou O, Niakas D. Psychometric properties of the Greek Haem-A-QoL for measuring quality of life in Greek haemophilia patients. BioMed Res Int. 2014;2014:968081.
Faranoush M, Shahverdi E, Ghorbani R, Moghaddam M. Health-related quality of life in Iranian adult men with severe hemophilia. Blood Coagul Fibrinol. 2017;28:638–41.
Aledort L, Bullinger M, von Mackensen S, Wasserman J, Young NL, Globe D, et al. Why should we care about quality of life in persons with haemophilia? Haemophilia. 2012;18:e154–7.
Oladapo AO, Epstein JD, Williams E, Ito D, Gringeri A, Valentino LA. Health-related quality of life assessment in haemophilia patients on prophylaxis therapy: a systematic review of results from prospective clinical trials. Haemophilia. 2015;21:e344–58.
Lindvall K, Von Mackensen S, Berntorp E. Quality of life in adult patients with haemophilia—a single centre experience from Sweden. Haemophilia. 2012;18:527–31.
Duncan N, Shapiro A, Ye X, Epstein J, Luo MP. Treatment patterns, health-related quality of life and adherence to prophylaxis among haemophilia A patients in the United States. Haemophilia. 2012;18:760–5.
PASS 15 Power Analysis and Sample Size Software [Computer software]. NCSS, LLC. Kaysville; available from: https://ncss.com/software/pass (2017). Accessed 15 Jun 2017.
Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale: Lawrence Erlbaum Associates; 1988.
Duncan N, Kronenberger W, Roberson C, Shapiro A. VERITAS-Pro: a new measure of adherence to prophylactic regimens in haemophilia. Haemophilia. 2010;16:247–55.
Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine. 2000;25(24):3186–91.
Miesbach W, Kalnins W. Adherence to prophylactic treatment in patients with haemophilia in Germany. Haemophilia. 2016;22:e367-374.
van Os SB, Troop NA, Sullivan KR, Hart DP. Adherence to prophylaxis in adolescents and young adults with severe haemophilia: a quantitative study with patients. PLoS ONE. 2017;12(1):e0169880.
Maruish ME (Ed.). User’s manual for the SF-36v2 Health Survey (3rd ed.). Lincoln, RI: QualityMetric Incorporated. ISBN: 1–891810–28–6
Babic-Banaszak A, Kovacic L, Kovacevic L, Vuletic G, Mujkic A, Ebling Z. Impact of war on health related quality of life in Croatia: population study. Croat Med J. 2002;43:396–402.
Juresa V, Ivankovic G, Vuletic G, Babic-Banaszak I, Srcek I, Mastilica M, et al. The croatian health survey—SF-36: I. General quality of life assessment. Coll Antropol. 2000;24:69–78.
Maslic Sersic D, Vuletic G. Psychometric evaluation and establishing norms of Croatian SF-36 health survey: framework for subjective health research. Croat Med J. 2006;47:95–102.
Logar Zakrajšek B, Bren A, Sočan G, Pajek J. Pilotna raziskava psihometričnih lastnosti vprašalnikov SF-36v2 in ESRD-SCL-TM za merjenje z zdravjem povezane kakovosti življenja bolnikov po presaditvi ledvice. Psihol Obz. 2018;12:1–11.
IBM Corp. IBM SPSS Statistics for Windows, Version 26.0. Armonk, NY: IBM Corp. Released 2019.
Ryu E. Effects of skewness and kurtosis on normal-theory based maximum likelihood test statistic in multilevel structural equation modeling. Behav Res Methods. 2011;43:1066–74.
Kim HY. Statistical notes for clinical researchers: assessing normal distribution (2) using skewness and kurtosis. Restor Dent Endod. 2013;38:52.
Dolatkhah R, Fakhari A, Pezeshki MZ, Shabanlouei R, Tavassoli N, Gholchin M. Social determinants and health-related dimensions of quality of life in adult patients with haemophilia. Haemophilia. 2014;20:376–81.
Cuesta-Barriuso R, López-Pina JA, Nieto-Munuera J, Sagarra-Valls G, Panisello-Royo JM, Torres-Ortuño A. Effectiveness of the Medtep Hemophilia online platform for adherence to prophylactic treatment in haemophilia patients: results from a 1-year observational study. Haemophilia. 2018;24:452–9.
Kempton CL, Recht M, Neff A, Wang M, Buckner TW, Soni A, et al. Impact of pain and functional impairment in US adults with haemophilia: Patient-reported outcomes and musculoskeletal evaluation in the pain, functional impairment and quality of life (P-FiQ) study. Haemophilia. 2018;24:261–70.
Windyga J, Lin VW, Epstein JD, Ito D, Xiong Y, Abbuehl BE, et al. Improvement in health-related quality of life with recombinant factor IX prophylaxis in severe or moderately severe haemophilia B patients: results from the BAX326 Pivotal Study. Haemophilia. 2014;20:362–8.
Stirratt MJ, Dunbar-Jacob J, Crane HM, Simoni JM, Czajkowski S, Hilliard ME, et al. Self-report measures of medication adherence behavior: recommendations on optimal use. Transl Behav Med. 2015;5:470–82.
Guedes VG, Corrente JE, Farrugia A, Thomas S, Wachholz PA, de Oliveira Vidal EI. Comparing objective and self-reported measures of adherence in haemophilia. Haemophilia. 2019;25:821–30.
Tiede A, Bonanad S, Santamaria A, Goldmann G, Canaro M, Palomero A, et al. Quality of electronic treatment records and adherence to prophylaxis in haemophilia and von Willebrand disease: systematic assessments from an electronic diary. Haemophilia. 2020;26:999–1008.
The authors would like to thank all the participants who took part in the study. The authors would like to thank the Indiana Hemophilia & Thrombosis Center, Inc. for providing VERITAS-Pro and OptumInsight Life Sciences, Inc. for providing SF-36v2 for use in this study. The authors would also like to thank Bianca Dobson for language editing of this publication.
No special funding was obtained.
Conflict of interests
The authors report no conflicts of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Bago, M., Butkovic, A., Preloznik Zupan, I. et al. Association between reported medication adherence and health-related quality of life in adult patients with haemophilia. Int J Clin Pharm 43, 1500–1507 (2021). https://doi.org/10.1007/s11096-021-01270-x
- Haemophilia A
- Haemophilia B
- Medication adherence
- Quality of life